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Abstract
Background: The progression of chronic kidney disease (CKD) remains one of the main challenges in clinical
nephrology. Therefore, identifying the pathophysiological mechanisms and the independent preventable risk
factors helps in decreasing the number of patients suffering end stage renal disease and slowing its progression.
Methods: Smoking data was analyzed in patients with CKD throughout 2005-2009. One hundred and ninety-eight
patients who had recently been diagnosed with stage three CKD or higher according to the National Kidney
Foundation (NKF) 2002 Classification were studied. The control group was randomly selected and then matched
with the case subjects using a computerized randomization technique. The relative risk was estimated by
computing odds ratio (OR) by using multinomial logistic regression in SPSS ® for Windows between the two
groups.
Results: Smoking significantly increases the risk of CKD (OR = 1.6, p = 0.009, 95% CI = 1.12-2.29). When compared
to nonsmokers, current smokers have an increased risk of having CKD (OR = 1.63 p = 0.02, 95% CI = 1.08-2.45),
while former smokers did not have a statistically significant difference. The risk increased with high cumulative
quantity (OR among smokers with > 30 pack-years was 2.6, p = 0.00, 95% CI = 1.53-4.41). Smoking increased the
risk of CKD the most for those classified as hypertensive nephropathy (OR = 2.85, p = 0.01, 95% CI = 1.27-6.39) and
diabetic nephropathy (2.24, p = 0.005, 95% CI = 1.27-3.96). No statistically significant difference in risk was found for
glomerulonephritis patients or any other causes.
Conclusion: This study suggests that heavy cigarette smoking increases the risk of CKD overall and particularly for
CKD classified as hypertensive nephropathy and diabetic nephropathy.
Background
Smoking, a well known risk factor for many diseases,
was recently proven to play an important role in renal
diseases. Studies showed that cigarette smoking is a risk
factor for the development and progression of chronic
kidney disease (CKD) in community [1,2]. In these stu-
dies, causes of CKD were heterogeneous, while other
s t u d i e si m p l i e dt h a tt h er e l a tionship between cigarette
smoking and kidney impairment varied among underly-
ing kidney diseases [3]. However, there is still uncer-
tainty whether every kidney disease is equally vulnerable
due to cigarette smoking. In this sense, further research
is required.
Since urinary albumin is a sensitive marker of glomer-
ular injury [4], it is conceivable that the relationship of
smoking to albuminuria indicates direct or indirect
renal damage induced by smoking. It is blamed for the
deterioration of kidney function by increasing the risk of
microalbuninuria [5], accelerating the progression from
microalbuminuria to proteinuria [6,7] and as a result to
diabetic nephropathy which leads to end stage renal dis-
ease (ESRD) [6,8]. In a prospective study with 794
patients who had non insulin dependent diabetes melli-
tus (NIDDM), who had no proteinuria at baseline, the
relative risk of developing gross proteinuria (> 300 mg/
day) during four years of observation was 2- to 2.5-fold
higher in heavy smokers when compared to subjects
who had never smoked [9]. Many studies also indicate a
relationship between smoking and renal function dete-
rioration in lupus patients, polycystic kidney disease,
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(GN) [10-12] and proximal tubular dysfunction [13,14].
This study aims to investigate the relationship
between cigarette smoking and chronic kidney disease,
and its effects on each type of renal failure.
Methods
Study Subjects and Data Collection
A cross-sectional study of 198 patients with CKD and
371 healthy control subjects were matched and studied.
Cases were patients admitted or referred to one of the
three tertiary hospitals affiliated with Aleppo university
during 2005-2009 and newly diagnosed with CKD with
estimated glomerular filtration rate (eGFR) of less than
60 mg/minute/1.73 m
2 (CKD stages 3-5, according to the
National Kidney Foundation (NKF) 2002 classification)
[15]. Patients with pre- or post-renal causes of CKD were
not included in the study. The type of renal disease was
determined by medical history, urinalysis, and renal
biopsy. Eligibility and final diagnosis was confirmed by a
university nephrologist who supervised the study. Case
participants were enrolled after being approved and all
were recently diagnosed with CKD. Control participants
were randomly selected and then matched in gender and
age from healthy people, using a computerized randomi-
zation technique based on Aleppo city national database.
Eligible control subjects were people from the commu-
nity who had no medical history of kidney disease, which
was confirmed by normal eGFR reading (more than 90
mg/minute/1.73 m
2) and a urine protein creatinine ratio
less than 0.15 [16]. A registered research coordinator
sent invitations through the mail. All measurements were
done after the participants provided verbal or written
consent and answered a questionnaire which included
questions regarding demographic information and his-
tory of their renal disease and smoking habit.
The U.S. National Library of Medicine, Medical Sub-
ject Headings (MeSH) define smoking as inhaling and
exhaling the smoke of tobaccoo rs o m e t h i n gs i m i l a rt o
tobacco available at http://www.who.int. To reduce the
probability that symptoms of early CKD are influenced
by tobacco use, the classification of former versus cur-
rent tobacco use was based on smoking status 5 years
before the interview. Regular cigarette smoking was
defined as smoking at least one cigarette per day for six
months or more. Regular smokers were classified into
either current regular smokers if they smoked during
the last five years or former regular smokers if they quit
more than five years ago. Tobacco consumption was
measured with a pack per year formula.
Statistical Analyses
As an estimate of the relative risk for CKD among
tobacco users compared with non-smokers, we
computed odds ratios (OR) in terms of SPSS® (IBM®,
Chicago IL. USA) for Microsoft Windows®, using multi-
nomial logistic regression. We studied smoking as a
relative risk for CKD, and then we studied former versus
current smoking for the same purpose. The next step
was to determine the relative risk of smoking for each
type of renal disease. We studied analgesic (aspirin or
paracetamol) use, body mass index (BMI), angiotensin-
converting enzyme inhibitors (ACEi) or angiotensin II
receptor blockers (ARBs) use, and hypertension (HTN)
as confounding factors; however these factors were
excluded from the final model because their inclusion
did not affect the risk estimates.
Results
One hundred and ninety-eight patients and 371 healthy
participants as the control group were included. The
most used tobacco form was as a cigarette, so we
ignored pipe and snuff usage.
Fifty one percent of case subjects and 49% of control
subjects were men (Table 1). The mean age of both
groups was 45.36 ± 15.95 years, the case subjects’ mean
Table 1 Characteristic distribution in the case and control
subjects
Cases
(n = 198)
Control
(n = 371)
P value
n %* n %**
Gender 0.57
Male 102 51.5 182 49
Female 96 48.5 189 51
Age (yr) 0.96
18-24 30 15.2 59 15.9
25-34 28 14.1 48 12.9
35-44 34 17.2 55 14.8
45-54 44 22.2 92 24.7
55-64 40 20.2 74 19.9
≥65 22 11.1 43 11.5
Medications
Any HTN medication 91 45.9 149 40.1 0.18
ACEi 83 41.9 127 34.2 0.07
ARBs 15 7.6 26 7 0.81
Beta blockers 72 36.4 105 28.3 0.04
Analgesic 40 20.2 70 18.9 0.70
BMI 0.14
Underweight 7 3.5 26 7
Normal weight 104 52.5 163 43.9
Overweight 56 28.3 115 30.9
Obesity 31 15.6 67 18
HTN 58 29.3 92 24.8 0.25
Diabetes Mellitus 56 28.3 99 26.7 0.68
*Of cases (n = 198). **Of control (n = 371).
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mean age was 45.47 ± 16.00 years.
A majority of the patients were in The National Kid-
ney Foundation Kidney Disease Outcomes Quality
Initiative (NKF KDOQI ™ stage 3 and 4 [15]. Seventy
percent had a creatinine level > 2 mg/dl. The median
overall value of the eGFR calculated by the Modification
of Diet in Renal Disease (MDRD) formula was 41 ml/
min/1.73 m
2. Forty five and a half percent of cases had
glomerulonephritis as a cause for their CKD, 28.3% dia-
betic nephropathy, 13.1% hypertensive nephropathy, and
13.1% had an unknown or other causes for CKD.
About 43% of case subjects had ever smoked cigar-
ettes regularly compared to 32% of control subjects.
Compared to never regularly smoking, former and cur-
rent regular smoking significantly increased the risk
of CKD (OR = 1.6, CI 95% 1.12-2.29, p = 0.009) and
(OR = 1.63, CI 95% 1.08-2.45, p = 0.02), respectively.
The risk of CKD did not reach a significant level for
former regular smokers (OR = 1.04, CI 95% 0.58-1.86,
p = 0.8). This risk was obviously increased with the
tobacco consumption, with OR = 2.6, CI 95% 1.53-4.41,
p = 0.00 for more than 30 pack/year, and OR = 2.04, CI
95% 1.08-3.88, p = 0.02 for 16-30 pack/year compared
to those who had never regularly smoked (Table 2).
Table 3 presents OR for different types of CKD.
Smoking was significantly associated with risk of CKD
caused by hypertension (OR = 2.85, CI 95% 1.27-6.39, p
= 0.01) and diabetic nephropathy (OR = 2.24, CI 95%
1.27-3.96, p = 0.005). This association did not reach a
significant level for risk of CKD caused by glomerulone-
phritis (OR = 1.09, CI 95% 0.67-1.78, p =0 . 7 )a n dt h e
other causes of CKD (OR = 1.53, CI 95% 0.68-3.44, p =
0.2). The control subjects were gathered from the same
socioeconomic background. We did not find any influ-
ence by body mass index, hypertension and analgesic
use on the final results.
Discussion
We found an important statistically significant risk of
CKD caused by smoking in hypertensive nephropathy
and diabetic nephropathy patients and a weak, statisti-
cally insignificant association between smoking and
CKD caused by glomerulonephritis.
Many studies indicate that the deleterious effect of
smoking on renal function is not merely restricted to
essential hypertension and diabetic nephropathy. Some
of these studies found that smoking is an independent
predictor of microalbuminuria in healthy patients with
primary hypertension. It is well known that urinary
albumin is a sensitive marker of glomerular injury [4],
and the fact that there is a relationship between smok-
ing and albuminuria indicates direct or indirect renal
damage induced by smoking. Mimran et al. [17] studied
lean subjects with essential hypertension and found that
the prevalence of microalbuminuria was almost double
in smokers as compared to non-smokers. Same results
were found in other studies [18,19]. Multiple Risk Factor
Intervention Trial (MRFIT) found an increased risk for
end-stage renal disease (ESRD) for smokers as compared
to non-smokers [20,21]. Such increased relative risk of
ESRD related to smoking (up to 1.69 for heavy smokers)
was independent of age, ethnicity, income, blood pres-
sure, diabetes mellitus, prior history of myocardial
infarction, or serum cholesterol.
Smoking causes kidney deterioration in diabetic
patients with adverse effects on four different aspects of
albumin excretion: It increases the risk of microalbumi-
nuria[5], shortens the time interval between onset of
diabetes and onset of albuminuria or proteinuria [6,7],
accelerates the rate of progression from microalbumi-
nuria to persistent proteinuria [22,23], and accelerates
the rate of progression of diabetic nephropathy to ESRD
[6,8]. Chase et al. [5] reported that in a group of 359
young subjects with IDDM the prevalence of borderline
(> 7.6 mcg/min) and abnormal (> 30 mcg/min) albumin
excretion rate was 2.8 fold higher in smokers than in
non-smokers. Sawicki et al. [24] calculated the adjusted
odds ratio for the progression of diabetic nephropathy
and found that the odds ratio was higher by a factor of
2.74 for each 10 pack/year smoking history. In this
study all patients were administered an intensified insu-
lin along with antihypertensive therapy so that the con-
founding effects of hyperglycemia and hypertension
were minimized. Similar results were found by Biesen-
bach et al. [ 8 ]w h i c hc o n c l u d e dt h a tt h er a t eo fl o s so f
Table 2 Smoking status and Odds ratio for chronic renal
failure
Cases Control OR
† (CI
95%)
P
n %* n %**
Ever regular smoking
No 112 56.5 251 67.7 1 (Reference) -
Yes 86 43.4 120 32.3 1.6 (1.12-2.29) 0.009
Regular smoking
Former 30 15.1 43 11.6 1.04(0.58-
1.86)
0.8
Current 56 28.2 77 20.8 1.63(1.08-
2.45)
0.02
No. of pack/years,
cigarettes
1-15 34 17.1 60 16.1 2.1(0.96-4.57) 0.06
16-30 16 8 29 7.8 2.04(1.08-
3.88)
0.028
> 30 36 18.1 31 8.3 2.6(1.53-4.41) 0.000
*Of cases (n = 198). **Of control (n = 371).
† Adjusted by age and gender.
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as compared to the non-smoking patients with insulin
dependent diabetes mellitus (IDDM), and by a factor of
1.66 among NIDDM patients.
To determine the risk factors for noninsulin depen-
dent diabetes in a cohort representative of middle aged
British men, Perry et al. [25] conducted a prospective
study on 7,735 males (40 to 59 years) and found that
smoking was associated with a 50% increased risk of
developing NIDDM. This increased risk may be related
to the fact that smoking aggravates insulin resistance in
healthy smokers [26].
Another question would be the effect of smoking ces-
sation on kidney function. In patients with IDDM,
Chase et al. [5] found that albuminuria improved signifi-
cantly when patients stopped smoking. Sawicki et al.
[ 2 4 ]s t u d i e d3 4s m o k e r s ,3 5n o n s m o k e r s ,a n d2 4e x -
smokers with type I diabetes, hypertension, and diabetic
nephropathy for one year and found that the progres-
sion of nephropathy was less common in nonsmokers
(11%) than in smokers (53%) and in patients who had
quit smoking (33%). They also found that accumulated
dose measured by pack/year was an independent predic-
tive factor for the progression of diabetic nephropathy.
One of the other diseases that exacerbate with smok-
ing is autosomal dominant polycystic kidney disease
(ADPKD), Chapman et al. [27] found that ADPKD
patients with established proteinuria had a greater pack/
year smoking history than their nonproteinuric counter-
parts did. Smoking is also responsible for renal function
deterioration in lupus nephritis, as a retrospective
cohort study of 160 adults found that smoking at the
time of onset of nephritis was an independent risk fac-
tor for the more rapid development of ESRD [10]. The
median time interval to terminal renal failure was 145
months in smokers, but more than 273 months in non-
smokers. These effects persisted in multivariable ana-
lyses adjusting for differences among patients in age,
gender, socioeconomic status, renal histology, and
immunosuppressive treatment. They also found that
the combination of smoking and hypertension resulted
in shorter times to renal failure compared with
nonsmoking hypertensive patients. This observation was
not found in another study conducted on 70 lupus
nephritis patients [28].
Appel et al. [29] studied 45 patients each 50 years of
age or older, beginning renal replacement therapy and
found that smoking aggravates renal artery stenosis.
This effect was explained by increased arthrogenesis
among smokers. In their study Wang et al. [30] stated
that there is different susceptibility to arthrogenesis
among smokers, and that the risk appears to be exces-
sively high in patients who are homozygous for the
endothelial nitric oxide synthase 4a (ecNOS4a) gene,
which predisposes to endothelial dysfunction.
A previous, hospital-based case-control study [12]
found a threefold increased risk for glomerulonephritis
associated with CKD among heavy smokers while other
studies did not find the same results. In a case-control
study including 55 patients and 55 normal subjects
Yaqoob et al. [31] reported that there was no significant
correlation between tobacco and the development of
primary glomerulonephritis. Merkel et al. [32] did not
find any evidence that smoking aggravates the course of
anti-glomerular basement membrane (anti-GBM) glo-
merulonephritis. Our study supports the observation
made by Yaqoob regarding the association between
smoking and the development of primary GN. However
it was found that smoking is significantly associated
with pulmonary hemorrhage in anti-GBM glomerulone-
phritis patients [33].
The increment of GFR induced by smoking may play
ar o l ei nt h eg e n e s i so fh y p e r filtration as a potential
mediator of accelerated progression of chronic renal dis-
ease [34,35]. Pawlik et al. [36] studied renal excretory
and circulatory responses to nicotine in anesthetized
dogs and found that nicotine causes an increase in
sodium and chloride excretion and urine flow, which is
reversed after the administration of propranolol or in
the group underwent adrenalectomy. This observation
leads to a conclusion that nicotine action on the kidney
is mediated by release of catecholamines from the adre-
nal medulla. Another mechanism could be the incre-
ment of vasopressin release secondary to altering
Table 3 Odds ratio for chronic renal failure by type among regular smokers
N (%*) Ever regular use of cigarettes OR
† (CI 95%) P
No
n (%**)
Yes
n (%+)
Control 371(65.2) 120(51.7) 251(74.5) 1 Reference -
Glomerulonephritis 90 (15.8) 59(25.4) 31(9.1) 1.09(0.67-1.78) 0.7
Diabetic nephropathy 56 (9.8) 27(11.6) 29(8.6) 2.24(1.27-3.96) 0.005
Hypertension 26 (4.6) 11(4.8) 15(4.5) 2.85(1.27-6.39) 0.011
Unknown and other causes 26 (4.6) 15(6.5) 11(3.3) 1.53(0.68-3.44) 0.2
*Of all subjects (n = 569). **Of never regular smokers (n = 232).
+Of ever regular smokers (n = 337).
† Adjusted by age and gender.
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which increases GFR inappropriately [37,38]. On the
other hand, the increment of GFR is thought to be due
to an intermittent and persistent increase in blood pres-
sure induced by smoking nicotine products; this blood
pressure alteration was absent in patient smoking nico-
tine-free cigarettes [39-41].
Smoking also alters the proximal tubular function
leading to increased excretion of N-acetyl-f3-glucosami-
nidase (NAG) and impairment of organic cation trans-
port [42] which correlates strongly with the amount of
tobacco consumed [13].
Conclusions
In conclusion, our study found that smoking, particu-
larly heavy smoking (> 30 pack/year), is an important
risk factor to the development of CKD. The association
was strongest for CKD classified as hypertension and
diabetic nephropathy. These results raise the importance
of smoking cessation to decrease the incidence of CKD
and other preventable diseases as COPD, coronary
artery diseases, and cancers.
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